Concepedia

Author

Aristides Polyzos

Laiko General Hospital of Athens

Also Known As

Aristides Polyzos

12

Publications

372

Citations

10

H-Index

21

Concepts

All Affiliations

Laiko General Hospital of AthensUniversity Hospital of HeraklionAthens State UniversityMetaxa HospitalNational and Kapodistrian University of Athens
AP

About

Aristides Polyzos is an author at Laiko General Hospital of Athens specializing in oncology, cancer therapeutics, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

149

2

Gastroenterology

3

3

33

3

Health Sciences

2

2

22

4

Obstetrics

2

2

62

5

Pathology

1

1

10

Aristides Polyzos

×

9

Publications

255

Citations

9

H-Index

YearCitations

Clinical Features of Hypersensitivity Reactions to Oxaliplatin: A 10-Year Experience

Aristides Polyzos, Nikolas Tsavaris, Hellen Gogas,

Oncology

2008

106

FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG)

Aristides Polyzos, Nikolaos Malamos, Ioannis Boukovinas,

Breast Cancer Research and Treatment

2009

42

A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer

Zacharenia Saridaki, Nikolaos Malamos, Panagiotis Kourakos,

Cancer Chemotherapy and Pharmacology

2011

32

Docetaxel in combination with irinotecan (CPT-11) in platinum-resistant paclitaxel-pretreated ovarian cancer.

Aristides Polyzos, Christos Kosmas, Helen Toufexi,

PubMed

2005

20

Salvage chemotherapy with oxaliplatin and capecitabine for breast cancer patients pretreated with anthracyclines and taxanes.

Aristides Polyzos, Helen Gogas, Christos Markopoulos,

PubMed

2009

12

Subsets of patients with advanced gastric cancer responding to second-line chemotherapy with docetaxel-cisplatin.

Aristides Polyzos, Nikolas Tsavaris, Christos Kosmas,

PubMed

2006

12

Phase I trial of weekly docetaxel with a 4-weekly cisplatin administration in patients with advanced gastric carcinoma

Aristides Polyzos, Konstantinos Syrigos, Christos Panopoulos,

Cancer Chemotherapy and Pharmacology

2005

11

Modified docetaxel-cisplatin in combination with capecitabine as first-line treatment in metastatic gastric cancer. a phase II study.

Aristides Polyzos, Evangellos Felekouras, Theodore Karatzas,

PubMed

2012

10

Docetaxel and epirubicin supported by granulocyte colony-stimulating factor first-line in advanced breast cancer.

Aristides Polyzos, N. Tsavaris, Christos Kosmas,

PubMed

2003

10

Page 1